-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, S11ERP7kKumfRepVYYlg6oCIfNuJh9vcX2Jgg/iDCs/RsbvYBSYST4GKM9qJ/LGm c3fHPGe3eNJkBr1r5H5g0A== 0000950159-03-000036.txt : 20030115 0000950159-03-000036.hdr.sgml : 20030115 20030115154632 ACCESSION NUMBER: 0000950159-03-000036 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20030115 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: GO2PHARMACY COM INC CENTRAL INDEX KEY: 0001098315 STANDARD INDUSTRIAL CLASSIFICATION: DAIRY PRODUCTS [2020] IRS NUMBER: 592600232 STATE OF INCORPORATION: FL FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-78678 FILM NUMBER: 03515014 BUSINESS ADDRESS: STREET 1: 6950 BRYAN DAIRY RD CITY: LARGO STATE: FL ZIP: 33777 BUSINESS PHONE: 7275448866 MAIL ADDRESS: STREET 1: 6950 BRYAN DAIRY RD CITY: LARGO STATE: FL ZIP: 33777 FORMER COMPANY: FORMER CONFORMED NAME: INNOVATIVE HEALTH PRODUCTS INC DATE OF NAME CHANGE: 19991103 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ZAPPALA JOSEPH CENTRAL INDEX KEY: 0001213648 FILING VALUES: FORM TYPE: SC 13G MAIL ADDRESS: STREET 1: 7227 CLINT MOORE ROAD CITY: BOCA RATON STATE: FL ZIP: 33496 SC 13G 1 zappala13g.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________ SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b)* Go2Pharmacy, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) 380193 10 2 - -------------------------------------------------------------------------------- (CUSIP Number) December 31, 2000 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [X] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). - -------------------------------------------------------------------------------- CUSIP No. 380193 10 2 13G Page 2 of 5 Pages - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON Joseph Zappala S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States of America - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER NUMBERS OF SHARES 1,875,000 BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH - -------------------------------------------------------------------------------- 6 SHARED VOTING POWER None - -------------------------------------------------------------------------------- 7 SOLE DISPOSITIVE POWER 1,375,000 - -------------------------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER None - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,875,000 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ] - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 26.7% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IN - -------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! -2- SCHEDULE 13G Item 1. 1(a). Name of Issuer: Go2Pharmacy, Inc. 1(b). Address of Issuer's Principal Executive Offices: 6950 Bryan Dairy Road, Largo, Florida, 33777 Item 2. 2(a). Name of Person Filing: Joseph Zappala 2(b). Address of Principal Business Office or, if None, Residence: 7227 Clint Moore Road, Boca Raton, Florida, 33496 2(c). Citizenship: United States 2(d). Title of Class of Securities: Common Stock, $.01 par value 2(e). CUSIP Number: 380193 10 2 Item 3. Not Applicable. Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: As of December 31, 2000, Joseph Zappala beneficially owned 1,875,000 shares of Common Stock. Of such shares, 1,375,000 shares are directly owned by Mr. Zappala. In addition, Mr. Zappala is deemed to be the beneficial owner of 500,000 shares of Common Stock owned by The Zappala Family LLC, and Mr. Zappala has sole voting rights with respect to such shares. (b) Percent of class: As of December 31, 2000, Mr. Zappala beneficially owned 26.7% of the Common Stock. (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: Mr. Zappala has the sole power to vote or to direct the vote of the 1,875,000 shares of Common Stock. -3- (ii) Shared power to vote or to direct the vote: None (iii) Sole power to dispose or to direct the disposition of: Mr. Zappala has the sole power to dispose or to direct the disposition of 1,375,000 shares of Common Stock. (iv) Shared power to dispose or to direct the disposition of: None Item 5. Ownership of Five Percent or Less of a Class Not Applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person All of the shares of Common Stock held in The Zappala Family LLC, over which Mr. Zappala has voting control, are beneficially owned by other members of the Zappala family. As such, the various beneficial owners of such shares have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such shares of Common Stock. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company Not applicable. Item 8. Identification and Classification of Members of the Group Not Applicable. Item 9. Notice of Dissolution of Group Not Applicable. Item 10. Certifications Not Applicable -4- SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. December 22, 2002 ------------------------ (Date) /s/ Joseph Zappala ------------------------ (Signature) Joseph Zappala ------------------------ (Name/Title) -5- -----END PRIVACY-ENHANCED MESSAGE-----